Introduction of the telemonitoring device Turbo+ in the management of patients suffering from asthma in Italy: a budget impact analysis
DOI:
https://doi.org/10.33393/grhta.2022.2290Keywords:
Adherence, Asthma, Budget impact analysis, Economic evaluation, TelemedicineAbstract
Introduction: Adherence to long-term asthma control drugs is one of the key factors in improving disease management among patients with asthma. Poor adherence to long-term therapies significantly compromises the effectiveness of treatment and represents a problem in controlling the disease in terms of quality of life and economic impact. A budget impact analysis has been developed taking into account that Turbo+ technology (electronic monitoring device) can increase adherence to therapy in patients suffering from asthma.
Methods: Coherently with the budget impact model methodology, we developed two different scenarios. One represents the clinical practice assuming a constant market share of 0,99% for Turbo+ and the other one assumes an incremental market share of Turbo+ over the time horizon considered. An increase in adherence to therapy will likely correspond to a reduction of exacerbations and a lower rate of hospitalizations, thus generating savings in terms of use of health resources.
Results: The differential analysis shows an incremental saving in terms of resources absorbed by the National Health Service (NHS) over the time horizon considered. In the first year the savings are equal to € 795,658.64 and in the fifth year they are equal to € 3,520,636.34 for a total of resources saved in 5 years of € 10,882,028.50.
Conclusions. The model shows how the diffusion of the Turbo+ programme can lead to savings in terms of health resources consumed by the NHS. Further analyses with new real-world data on adherence in asthmatic patients could be useful in confirming the results of the present analysis.
Downloads
References
Global Asthma Network. The Global Asthma Report 2018. Online: http://globalasthmanetwork.org/Global%20Asthma%20Report%202018.pdf ; (Accessed June 2021)
Vos T, Lim SS, Abbafati C, et al; GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-1222. https://doi.org/10.1016/S0140-6736(20)30925-9 PMID:33069326 DOI: https://doi.org/10.1016/S0140-6736(20)30925-9
Brian C. Leutholtz, Ignacio Ripoll, Exercise and disease management, 2nd. CRC Press; 2011:100. DOI: https://doi.org/10.1201/b10856
Global Initiative for Asthma (GINA) - Global Strategy for Asthma Management and Prevention; Online: https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf; (Accessed May 2021)
Johansson G, Andreasson EB, Larsson PE, Vogelmeier CF. Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma. Pharmacoeconomics. 2006;24(7):695-708. https://doi.org/10.2165/00019053-200624070-00008 PMID: 16802845. DOI: https://doi.org/10.2165/00019053-200624070-00008
Vogelmeier C, D’Urzo A, Pauwels R, et al. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J. 2005;26(5):819-828. https://doi.org/10.1183/09031936.05.00028305 PMID:16264042 DOI: https://doi.org/10.1183/09031936.05.00028305
Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO; Online: https://www.who.int/publications/i/item/9789240002319 (Accessed May 2021)
Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114(6):1288-1293. PMID:15577825 https://doi.org/10.1016/j.jaci.2004.09.028PMID:15577825 DOI: https://doi.org/10.1016/j.jaci.2004.09.028
Engelkes M, Janssens HM, de Jongste JC, Sturkenboom MC, Verhamme KM. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J. 2015;45(2):396-407. PMID:25323234 https://doi.org/10.1183/09031936.00075614PMID:25323234 DOI: https://doi.org/10.1183/09031936.00075614
L’uso dei farmaci in Italia – Rapporto nazionale anno 2019; Online: https://www.aifa.gov.it/documents/20142/1205984/rapporto-osmed-2019.pdf; (Accessed May 2021)
Agenzia Italiana del Farmaco (AIFA); Online: https://www.aifa.gov.it/liste-farmaci-a-h (Accessed May 2021)
Istituto Nazionale di Statistica – Popolazione residente al 1° gennaio – Online: http://dati.istat.it/Index.aspx?DataSetCode=DCIS_POPRES1; (Accessed May 2021)
Jensen, F.F., Håkansson, K.E.J., Overgaard Nielsen, B. et al. Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma. Asthma Res Pract. 2021 May 31;7(1):7. https://doi.org/10.1186/s40733-021-00072-2 PMID: 34059120 DOI: https://doi.org/10.1186/s40733-021-00072-2
Pesce G, Locatelli F, Cerveri I, et al. Seventy Years of Asthma in Italy: Age, Period and Cohort Effects on Incidence and Remission of Self-Reported Asthma from 1940 to 2010. PLoS One. 2015;10(10):e0138570. https://doi.org/10.1371/journal.pone.0138570 PMID:26439263 DOI: https://doi.org/10.1371/journal.pone.0138570
Antonicelli L, Bucca C, Neri M, et al. Asthma severity and medical resource utilisation. Eur Respir J. 2004;23(5):723-729. PMID:15176687 https://doi.org/10.1183/09031936.04.00004904PMID:15176687 DOI: https://doi.org/10.1183/09031936.04.00004904
Ministero della Salute - Tariffario delle prestazioni di assistenza specialistica per acuti (DRG); Online: http://www.salute.gov.it/portale/temi/p2_6.jsp?lingua=italiano&id=3662&area=programmazioneSanitariaLea&menu=vuoto (Accessed May 2021)
Prestazioni Di Assistenza Specialistica Ambulatoriale – Allegato III – Online: https://www.trovanorme.salute.gov.it/norme/renderPdf.spring?seriegu=SG&datagu=28/01/2013&redaz=13A00528&artp=3&art=1&subart=1&subart1=10&vers=1&prog=001; (Accessed May 2021)
Ministero della Salute – Telemedicina – Linee di indirizzo Nazionali. Online: https://www.salute.gov.it/portale/ehealth/dettaglioContenutiEHealth.jsp?lingua=italiano&id=5525&area=eHealth&menu=telemedicina (Accessed May 2021)
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 The authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors contributing to Global & Regional Health Technology Assessment agree to publish their articles under the CC-BY-NC 4.0 license, which allows third parties to re-use the work without permission as long as the work is properly referenced and the use is non-commercial.
Accepted 2022-03-14
Published 2022-04-19
